Active Not Recruiting NA INTERVENTIONAL 2-arm NCT01688908

Efficacy of Endoscopy Screening on Esophageal Cancer in China (ESECC) (ESECC)

Effcacy of Endoscopic Screening for Esophageal Cancer in China (ESECC): a Population-based Randomized Controlled Trial

Sponsor: Peking University

Conditions Dysplasia Esophageal Squamous Cell Carcinoma

Updated 6 times since 2017 Last updated: Jan 18, 2018 Started: Jan 1, 2012 Primary completion: Dec 31, 2022 Completion: Dec 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Dysplasia and Esophageal Squamous Cell Carcinoma, this trial is ongoing. The trial is conducted by Peking University and has accumulated 6 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Active Not Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting NA
Jan 2021 — Jul 2024 [monthly]

Active Not Recruiting NA
Jun 2018 — Jan 2021 [monthly]

Active Not Recruiting NA
Feb 2018 — Jun 2018 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting

▶ Show 1 earlier version

Jan 2017 — Feb 2018 [monthly]

Recruiting NA

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Peking University

Data source: Peking University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China